Vi Partners is proud to be investing in the 7𝐦€ round of German #Healthtech startup XO Life, together with Sandwater, Grazia Equity and Bayern Kapital, and existing investors. We are delighted to support Founder & CEO Dr. Friderike Bruchmann and her team to boost the expansion of XO Life's #𝐈𝐦𝐩𝐚𝐜𝐭𝐌𝐨𝐧𝐢𝐭𝐨𝐫 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦. XO Life is a #healthtech company that connects patients, experts, and pharmaceutical companies through its digital platform ImpactMonitor™. This platform offers a one-stop solution for digital product and treatment support, enabling pharmaceutical and medical device manufacturers to provide personalized and expert-driven guidance to patients. It also allows companies to gather real-world patient insights and streamline pharmacovigilance processes. The goal is to improve patient outcomes through better information, support, and engagement. Arnd Kaltofen-Ehmann, Partner at Vi Partners "The combination of sound medical information and an intuitive platform is tailored to today's patient needs. In addition, the Impact-Monitor™️ platform provides physicians, medical institutions and companies with valuable insights into the needs and preferences of users and can thus support the development of new, patient-oriented therapies." https://lnkd.in/eiXGBcEi
Co-Founder & CEO at XO Life | Enabling better Patient Education, Treatment Support and Real World Evidence 🌎 | Top 10 Startups Digital Hub by Bundesministerium für Wirtschaft und Klimaschutz
🥹 Words cannot describe how this post makes me feel right now: 🎉🎉🎉 Absolutely thrilled to announce that XO Life 𝐡𝐚𝐬 𝐫𝐚𝐢𝐬𝐞𝐝 𝐄𝐔𝐑 7𝐦 𝐟𝐫𝐨𝐦 𝐚 𝐬𝐭𝐫𝐨𝐧𝐠 𝐕𝐂 𝐬𝐲𝐧𝐝𝐢𝐜𝐚𝐭𝐞 with Sandwater and Grazia Equity as lead investors, Vi Partners and Bayern Kapital as co-leads, and the participation of our existing investors such as aescuvest, Isartal Ventures, Winning Mindset, MediVentures GmbH, capacura and new investors especially from the healthcare and pharma sector. With this funding, we will take XO Life and our 𝐮𝐧𝐢𝐪𝐮𝐞 𝐈𝐦𝐩𝐚𝐜𝐭𝐌𝐨𝐧𝐢𝐭𝐨𝐫 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐭𝐨 𝐭𝐡𝐞 𝐢𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐥𝐞𝐯𝐞𝐥 𝐚𝐧𝐝 𝐨𝐟𝐟𝐞𝐫 𝐢𝐭 𝐢𝐧 𝐨𝐭𝐡𝐞𝐫 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐜𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 𝐚𝐧𝐝 𝐛𝐞𝐲𝐨𝐧𝐝! 👩🏻💻🧑🏼💻 Months of hard work have gone into this achievement and we wouldn't be here today if our team of 30 employees, 13 nationalities weren't incredibly dedicated and supportive and working with all their #energy and #passion on our big vision: 𝐄𝐧𝐚𝐛𝐥𝐞 𝐞𝐯𝐞𝐫𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐰𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞 𝐭𝐨 𝐠𝐞𝐭 𝐭𝐡𝐞 𝐛𝐞𝐬𝐭 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞𝐢𝐫 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐩𝐫𝐨𝐝𝐮𝐜𝐭, 𝐨𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭! 🤝 We are also delighted to have a strong 𝐕𝐂 𝐬𝐲𝐧𝐝𝐢𝐜𝐚𝐭𝐞 consisting of 𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥, 𝐢𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥, 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐚𝐧𝐝 𝐒𝐚𝐚𝐒-focussed VCs by our side - during harsh times when the capital market almost came to a standstill and the digital health sector also has suffered major setbacks. 💸🌎 We are using the newly acquired funds to expand to #Europe and beyond, because digital support for patients is needed in every country. With our ImpactMonitor platform, we make this easily possible - with the best user engagement in one meta app for an entire industry. 🧑🏻⚕️🩺 Already today, we work together with 5% of 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬, 𝐟𝐫𝐨𝐦 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐥𝐞𝐚𝐝𝐞𝐫𝐬 𝐭𝐨 𝐒𝐌𝐄 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐢𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 such as the Charité and EORTC - European Organisation for Research and Treatment of Cancer, doctors, pharmacies and of course patients. 🥹 If someone had told me 3 years ago that we would make it to this milestone, I would have always wished for it, but everyone knows what the true entrepreneurial reality is. More than ever, we feel encouraged and inspired in what we do every day! 🥳 Many thanks to the entire XO Life team, especially to Schirin Yazgan, Christian Keller, Frederick Kühl, Scott Weiss, Jochen Hurlebaus, Moritz Miersch! 👏 To our new investors under the patronage of Morten E. Iversen, Katherine Mellis, Jochen Klueppel, Alec Rauschenbusch, Dr. Benedikt Battke, Arnd Kaltofen-Ehmann, Franziska P., Martin Redl 👏 To the existing investors under the patronage of Dr. Patrick Pfeffer, Christoph Bartoschek, Ingo Dahm, Andreas Arntzen, Kai Langohr, Melina Kosak, Philipp Große and many more. It feels like we're just getting started...😎